tiprankstipranks
Trending News
More News >
Manzo Pharmaceuticals (MNZO)
OTHER OTC:MNZO
US Market

Manzo Pharmaceuticals (MNZO) Income Statement

Compare
1 Followers

Manzo Pharmaceuticals Income Statement

Last quarter (Q0 0), Manzo Pharmaceuticals's total revenue was $―, a decrease of ― from previous quarter. In Q0, Manzo Pharmaceuticals's net income was $-1.23M. See Manzo Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 04Dec 03
Total Revenue
$ ―$ ―
Gross Profit
$ 20.97K$ 755.89K
Operating Expenses
$ ―$ ―
Depreciation and Amortization
$ ―$ ―
EBITDA
$ -2.85M$ -2.30M
Operating Income
$ -3.20M$ -3.25M
Other Income/Expenses
$ ―$ ―
Pretax Income
$ ―$ ―
Net Income
$ -4.15M$ -3.95M
Per Share Metrics
Basic EPS
$ ―$ ―
Diluted EPS
$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Manzo Pharmaceuticals Earnings and Revenue History